Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E02-11-0726 on July 11, 2003

Vol. 14, Issue 10, 4155-4161, October 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E02-11-0726v1
14/10/4155    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riley, K. N.
Right arrow Articles by Herman, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riley, K. N.
Right arrow Articles by Herman, I. M.

{beta}cap73-ARF6 Interactions Modulate Cell Shape and Motility after Injury In Vitro

Kathleen N. Riley *, Angel E. Maldonado *, Patrice Tellier *, Crislyn D'Souza-Schorey {dagger}, and Ira M. Herman * {ddagger}

* Cell and Molecular Physiology, Tufts University School of Medicine, Boston, Massachusetts 62111; {dagger} Biology Department, University of Notre Dame, Notre Dame, Indiana 46556

Submitted November 12, 2002; Revised May 13, 2003; Accepted May 30, 2003
Monitoring Editor: Paul Matsudaira

To understand the role that ARF6 plays in regulating isoactin dynamics and cell motility, we transfected endothelial cells (EC) with HA-tagged ARF6: the wild-type form (WT), a constitutively-active form unable to hydrolyze GTP (Q67L), and two dominant-negative forms, which are either unable to release GDP (T27N) or fail to bind nucleotide (N122I). Motility was assessed by digital imaging microscopy before Western blot analysis, coimmunoprecipitation, or colocalization studies using ARF6, {beta}-actin, or {beta}-actin-binding protein-specific antibodies. EC expressing ARF6-Q67L spread and close in vitro wounds at twice the control rates. EC expressing dominant-negative ARF6 fail to develop a leading edge, are unable to ruffle their membranes (N122I), and possess arborized processes. Colocalization studies reveal that the Q67L and WT ARF6-HA are enriched at the leading edge with {beta}-actin; but T27N and N122I ARF6-HA are localized on endosomes together with the {beta}-actin capping protein, {beta}cap73. Coimmunoprecipitation and Western blot analyses reveal the direct association of ARF6-HA with {beta}cap73, defining a role for ARF6 in signaling cytoskeletal remodeling during motility. Knowledge of the role that ARF6 plays in orchestrating membrane and {beta}-actin dynamics will help to reveal molecular mechanisms regulating actin-based motility during development and disease.


Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02–11–0726. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-11-0726.

{ddagger} Corresponding author. E-mail address: ira.herman{at}tufts.edu.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2003 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.